Steve Chaussy - 01 Sep 2022 Form 4 Insider Report for BioSig Technologies, Inc. (BSGM)

Reporting relationship: Chief Financial Officer
Issuer ticker: BSGM
Reported as of: 01 Sep 2022
Net transaction value: +$12,929
SEC form: 4
Accepted by SEC: 02 Sep 2022, 09:35:39 UTC
Prior SEC filing: 24 Aug 2022
Source filing: View source filing
Reporting owner signature: /s/ Steve Chaussy

Key filing fact

Steve Chaussy filed Form 4 for BioSig Technologies, Inc. (BSGM) on 02 Sep 2022.

Key facts

This page summarizes Steve Chaussy's Form 4 filing for BioSig Technologies, Inc. (BSGM).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Sep 2022, 09:35.

Change

Previous filing in this sequence was filed on 24 Aug 2022.
Current net transaction value: +$12,929.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BSGM transaction

Common Stock

Purchase

Transaction value: $12,929
Shares: +11,425
Change %: +1.1%
Price: $1.13
Shares after: 1,051,553
Date: 01 Sep 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.125 to $1.14, inclusive. The reporting person undertakes to provide to BioSig Technologies, Inc., any security holder of BioSig Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.